1. Home
  2. ARKO vs ESPR Comparison

ARKO vs ESPR Comparison

Compare ARKO & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARKO Corp.

ARKO

ARKO Corp.

HOLD

Current Price

$7.47

Market Cap

737.0M

Sector

Energy

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.13

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARKO
ESPR
Founded
1970
2008
Country
United States
United States
Employees
9748
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
737.0M
731.9M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
ARKO
ESPR
Price
$7.47
$3.13
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$7.50
$8.75
AVG Volume (30 Days)
814.0K
16.9M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
1.91%
N/A
EPS Growth
N/A
60.71
EPS
N/A
N/A
Revenue
N/A
$403,135,000.00
Revenue This Year
$12.86
N/A
Revenue Next Year
$1.49
$12.81
P/E Ratio
$56.88
N/A
Revenue Growth
N/A
21.31
52 Week Low
$3.71
$0.79
52 Week High
$7.50
$4.18

Technical Indicators

Market Signals
Indicator
ARKO
ESPR
Relative Strength Index (RSI) 73.28 70.22
Support Level $4.80 $3.11
Resistance Level N/A $3.18
Average True Range (ATR) 0.30 0.02
MACD 0.05 0.01
Stochastic Oscillator 99.59 21.43

Price Performance

Historical Comparison
ARKO
ESPR

About ARKO ARKO Corp.

ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. It derives the majority of its revenue from retail and wholesale distribution of fuel.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: